References

1. Jain KK. Recent advances in oncoproteomics. Curr Opin Mol Ther 2002; 4:203-209.

2. Chen G, Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002; 8:2298-2305.

3. Hanash SM, Madoz-Gurpide J, Misek DE. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 2002; 16:478-485.

4. Emmert-Buck MR, Gillespie JW, Paweletz CP, et al. An approach to proteomic analysis of human tumors. Mol Carcinog 2000; 27:158-165.

5. Jain KK. Proteomics: technologies, markets and companies. Basel: Jain PharmaBiotech, 2004.

6. Jain KK. Application of laser capture microdissection to proteomics. Methods Enzymol 2002; 356: 157-167.

7. Bichsel VE, Liotta LA, Petricoin EF 3rd. Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J 2001; 7:69-78.

8. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol 2000; 53:666-672.

9. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003; 3:267-275.

10. Grubb RL, Calvert VS, Wulkuhle JD, et al. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003; 3:2142-2146.

11. Li JJ, Fang X, Tan W. Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun 2002; 292:31-40.

12. Verma M, Kagan J, Sidransky D, Srivastava S. Proteomic analysis of cancer-cell mitochondria. Nat Rev Cancer 2003; 3:789-795.

13. Welsh JB, Sapinoso LM, Kern SG, et al. Large-scale delineation of secreted protein biomarkers over-expressed in cancer tissue and serum. PNAS 2003; 100:3410-3415.

14. Nicosia SV, Bai W, Cheng JQ, et al. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am 2003; 17:927-943.

15. McKerrow JH, Bhargava V, Hansell E, et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 2000; 6:450-460.

16. Ficarro SB, McCleland ML, Stukenberg PT, et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 2002; 20:301-305.

17. Hao D, Rowinsky EK. Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors. Cancer Invest 2002; 20:387-404.

18. Glen RC, Allen SC. Ligand-protein docking: cancer research at the interface between biology and chemistry. Curr Med Chem 2003; 10:763-767.

19. Borbat PP, Costa-Filho AJ, Earle KA, et al. Electron spin resonance in studies of membranes and proteins. Science 2001; 291:266-269.

20. Enyedy IJ, Ling Y, Nacro K, et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem 2001; 44:4313-4324.

21. Lindsay MA. Target discovery. Nat Rev Drug Discov 2003; 2:831-838.

22. Jain KK. Role of oncoproteomics in the personalized management of cancer. Expert Rev Proteomics 2004; 1:49-55.

23. Fang Y, Frutos AG, Lahiri J. Membrane protein microarrays. J Am Chem Soc 2002; 124:2394-2395.

0 0

Post a comment